CVR PARTNERS LP (UAN)

US1266332055

75.95  +0.81 (+1.08%)

Fundamental Rating

5

Overall UAN gets a fundamental rating of 5 out of 10. We evaluated UAN against 83 industry peers in the Chemicals industry. While UAN belongs to the best of the industry regarding profitability, there are some minor concerns on its financial health. UAN has a valuation in line with the averages, but it does not seem to be growing.



8

1. Profitability

1.1 Basic Checks

In the past year UAN was profitable.
UAN had a positive operating cash flow in the past year.
In multiple years UAN reported negative net income over the last 5 years.
Each year in the past 5 years UAN had a positive operating cash flow.

1.2 Ratios

UAN has a better Return On Assets (5.33%) than 78.31% of its industry peers.
Looking at the Return On Equity, with a value of 18.30%, UAN belongs to the top of the industry, outperforming 85.54% of the companies in the same industry.
UAN's Return On Invested Capital of 7.35% is fine compared to the rest of the industry. UAN outperforms 69.88% of its industry peers.
UAN had an Average Return On Invested Capital over the past 3 years of 18.29%. This is significantly above the industry average of 7.24%.
The 3 year average ROIC (18.29%) for UAN is well above the current ROIC(7.35%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 5.33%
ROE 18.3%
ROIC 7.35%
ROA(3y)16.89%
ROA(5y)7.62%
ROE(3y)49.81%
ROE(5y)21.97%
ROIC(3y)18.29%
ROIC(5y)11.54%

1.3 Margins

The Profit Margin of UAN (9.97%) is better than 84.34% of its industry peers.
UAN's Operating Margin of 15.56% is amongst the best of the industry. UAN outperforms 83.13% of its industry peers.
UAN's Operating Margin has improved in the last couple of years.
UAN has a better Gross Margin (36.95%) than 73.49% of its industry peers.
UAN's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 15.56%
PM (TTM) 9.97%
GM 36.95%
OM growth 3Y149.63%
OM growth 5Y73.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.69%
GM growth 5Y9.26%

4

2. Health

2.1 Basic Checks

UAN has a Return on Invested Capital (ROIC), which is well above the Cost of Capital (WACC), which means it is creating value.
UAN has less shares outstanding than it did 1 year ago.
The number of shares outstanding for UAN has been reduced compared to 5 years ago.
The debt/assets ratio for UAN is higher compared to a year ago.

2.2 Solvency

The Debt to FCF ratio of UAN is 6.04, which is on the high side as it means it would take UAN, 6.04 years of fcf income to pay off all of its debts.
UAN's Debt to FCF ratio of 6.04 is fine compared to the rest of the industry. UAN outperforms 63.86% of its industry peers.
A Debt/Equity ratio of 1.91 is on the high side and indicates that UAN has dependencies on debt financing.
UAN has a Debt to Equity ratio of 1.91. This is amonst the worse of the industry: UAN underperforms 87.95% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 6.04
Altman-Z N/A
ROIC/WACC0.95
WACC7.77%

2.3 Liquidity

A Current Ratio of 2.15 indicates that UAN has no problem at all paying its short term obligations.
UAN has a Current ratio (2.15) which is in line with its industry peers.
A Quick Ratio of 1.44 indicates that UAN should not have too much problems paying its short term obligations.
UAN has a Quick ratio (1.44) which is in line with its industry peers.
Industry RankSector Rank
Current Ratio 2.15
Quick Ratio 1.44

1

3. Growth

3.1 Past

UAN shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -79.62%.
The Revenue for UAN has decreased by -29.88% in the past year. This is quite bad
Measured over the past years, UAN shows a quite strong growth in Revenue. The Revenue has been growing by 14.18% on average per year.
EPS 1Y (TTM)-79.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%414.29%
Revenue 1Y (TTM)-29.88%
Revenue growth 3Y24.87%
Revenue growth 5Y14.18%
Sales Q2Q%-4.13%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.

5

4. Valuation

4.1 Price/Earnings Ratio

UAN is valuated correctly with a Price/Earnings ratio of 15.28.
UAN's Price/Earnings ratio is a bit cheaper when compared to the industry. UAN is cheaper than 68.67% of the companies in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 27.54, UAN is valued a bit cheaper.
Industry RankSector Rank
PE 15.28
Fwd PE N/A

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of UAN indicates a rather cheap valuation: UAN is cheaper than 80.72% of the companies listed in the same industry.
85.54% of the companies in the same industry are more expensive than UAN, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.86
EV/EBITDA 7.44

4.3 Compensation for Growth

UAN has an outstanding profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

5

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 9.14%, UAN is a good candidate for dividend investing.
Compared to an average industry Dividend Yield of 3.35, UAN pays a better dividend. On top of this UAN pays more dividend than 95.18% of the companies listed in the same industry.
UAN's Dividend Yield is rather good when compared to the S&P500 average which is at 2.36.
Industry RankSector Rank
Dividend Yield 9.14%

5.2 History

UAN has paid a dividend for at least 10 years, which is a reliable track record.
UAN has decreased its dividend in the last 3 years.
Dividend Growth(5Y)N/A
Div Incr Years2
Div Non Decr Years2

5.3 Sustainability

141.68% of the earnings are spent on dividend by UAN. This is not a sustainable payout ratio.
DP141.68%
EPS Next 2YN/A
EPS Next 3YN/A

CVR PARTNERS LP

NYSE:UAN (12/24/2024, 7:42:54 PM)

75.95

+0.81 (+1.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)10-28 2024-10-28/amc
Earnings (Next)02-18 2025-02-18
Inst Owners43.08%
Inst Owner Change-0.52%
Ins Owners0.36%
Ins Owner Change0%
Market Cap802.79M
Analysts45
Price TargetN/A
Short Float %0.81%
Short Ratio2.14
Dividend
Industry RankSector Rank
Dividend Yield 9.14%
Dividend Growth(5Y)N/A
DP141.68%
Div Incr Years2
Div Non Decr Years2
Ex-Date11-08 2024-11-08 (1.19)
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 15.28
Fwd PE N/A
P/S 1.52
P/FCF 8.86
P/OCF 6.7
P/B 2.79
P/tB 2.79
EV/EBITDA 7.44
EPS(TTM)4.97
EY6.54%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)8.58
FCFY11.29%
OCF(TTM)11.34
OCFY14.93%
SpS49.89
BVpS27.19
TBVpS27.19
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 5.33%
ROE 18.3%
ROCE 9.31%
ROIC 7.35%
ROICexc 8.41%
ROICexgc 8.41%
OM 15.56%
PM (TTM) 9.97%
GM 36.95%
FCFM 17.19%
ROA(3y)16.89%
ROA(5y)7.62%
ROE(3y)49.81%
ROE(5y)21.97%
ROIC(3y)18.29%
ROIC(5y)11.54%
ROICexc(3y)19.93%
ROICexc(5y)12.55%
ROICexgc(3y)19.93%
ROICexgc(5y)12.57%
ROCE(3y)23.15%
ROCE(5y)14.61%
ROICexcg growth 3Y220.17%
ROICexcg growth 5Y105.3%
ROICexc growth 3Y220.17%
ROICexc growth 5Y106.91%
OM growth 3Y149.63%
OM growth 5Y73.24%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y16.69%
GM growth 5Y9.26%
F-Score4
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 1.91
Debt/FCF 6.04
Debt/EBITDA 3.29
Cap/Depr 34.51%
Cap/Sales 5.54%
Interest Coverage 2.4
Cash Conversion 71.9%
Profit Quality 172.41%
Current Ratio 2.15
Quick Ratio 1.44
Altman-Z N/A
F-Score4
WACC7.77%
ROIC/WACC0.95
Cap/Depr(3y)37.61%
Cap/Depr(5y)32.14%
Cap/Sales(3y)4.26%
Cap/Sales(5y)4.54%
Profit Quality(3y)143.9%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-79.62%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%414.29%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.88%
Revenue growth 3Y24.87%
Revenue growth 5Y14.18%
Sales Q2Q%-4.13%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.48%
EBIT growth 3Y211.72%
EBIT growth 5Y97.81%
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-72.43%
FCF growth 3Y484.21%
FCF growth 5Y77.64%
OCF growth 1Y-67.83%
OCF growth 3Y131.22%
OCF growth 5Y49.88%